Intranasal Administration of Genetically Modified Lactococcus Lactis Producing PD-L1 scFv Improves Survival in Lung Cancer Model Mice

被引：0
|
作者：
Nomura, N. [1 ]
Namai, F. [1 ]
Sato, T. [1 ]
Shimosato, T. [1 ]
机构：
[1] Shinshu Univ, Inst Biomed Sci, Nagano, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5754
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-L1 expression and survival in stage III unresectable non-small cell lung cancer patients in Denmark
    Cronin-Fenton, D.
    Dalvi, T.
    Movva, N.
    Pedersen, L.
    Hansen, H.
    Fryzek, J.
    Mellemgaard, A.
    Rasmussen, T.
    Klein, A. B.
    Hamilton-Dutoit, S.
    Norgaard, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S808 - S808
  • [22] Association of PD-L1 expression with clinicopathologic features and overall survival in patients with non-small-cell lung cancer
    Zhou, Yan
    Liu, Xianxun
    Hu, Zhangguo
    Zhong, Runbo
    Han, Baohui
    Zhong, Hua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (02): : 1954 - 1961
  • [23] Rhamnazin Enhanced Anti-Tumor Efficacy of Anti-PD-1 Therapy for Lung Cancer in Mice through Inhibition of PD-L1 Expression
    Wang, Shu Shi
    Liu, Ye
    Zhang, Xuan Ting
    Yu, Dong Qiang
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 260 (01): : 63 - 73
  • [24] PD-L1 Expression and Survival among Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy
    Sorensen, Steffen Filskov
    Zhou, Wei
    Dolled-Filhart, Marisa
    Georgsen, Jeanette Baehr
    Wang, Zhen
    Emancipator, Kenneth
    Wu, Dianna
    Busch-Sorensen, Michael
    Meldgaard, Peter
    Hager, Henrik
    TRANSLATIONAL ONCOLOGY, 2016, 9 (01): : 64 - 69
  • [25] PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival data
    Aguiar, Pedro N., Jr.
    De Mello, Ramon Andrade
    Hall, Peter
    Tadokoro, Hakaru
    de Lima, Gilberto
    IMMUNOTHERAPY, 2017, 9 (06) : 499 - 506
  • [26] RNA Sequencing Reveals Unique Transcriptomic Signatures of the Thyroid in a Murine Lung Cancer Model Treated with PD-1 and PD-L1 Antibodies
    Pollack, Rena
    Stokar, Joshua
    Lishinsky, Natan
    Gurt, Irina
    Kaisar-Iluz, Naomi
    Shaul, Merav E. E.
    Fridlender, Zvi G. G.
    Dresner-Pollak, Rivka
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [27] Non-small cell lung cancer cells induce PD-L1 expression in the tumor microenvironment in an orthotopic mouse model of lung cancer
    Li, Howard
    McSharry, Maria
    Clambey, Eric
    Nguyen, Teresa
    McNamee, Eoin
    Weiser-Evans, Mary
    Nemenoff, Raphael
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [28] Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer
    Sepesi, Boris
    Cuentas, Edwin Parra
    Canales, Jaime Rodriguez
    Behrens, Carmen
    Correa, Arlene M.
    Vaporciyan, Ara
    Weissferdt, Annikka
    Kalhor, Neda
    Moran, Cesar
    Swisher, Stephen
    Wistuba, Ignacio
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2017, 29 (03) : 408 - 415
  • [29] High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer
    Jing, Wang
    Wang, Shijiang
    Ding, Xiao
    Guo, Hongbo
    Li, Ji
    Wang, Haiyong
    Kong, Li
    Yu, Jinming
    Zhu, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2675 - 2682
  • [30] The Level of Programmed Cell Death Ligand 1 (PD-L1) Could Predict Survival of Patients with Resectable Small Cell Lung Cancer
    Jing, W.
    Zhu, H.
    Yu, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2366 - S2366
12345